| 摘要 |
<p>A method and use are provided for the treatment of angina pectoris in humans, comprising the administration of an effective amount of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone to a human in need of such treatment. Preferably the active compound is administered in an amount of at least 50 mg, once a day.</p> |
